OAR 845-025-7100: Cannabinoid Concentrate and Extract Labeling Requirements

Prior to a cannabinoid concentrate or extract being sold or transferred to a consumer, patient or designated primary caregiver the container holding the concentrate or extract must have a label that has the following information: (1) Processor’s business or trade name and license number; (2) Business or trade name of licensee that packaged the product, if different from the processor; (3) UID number; (4) Product identity that correctly identifies the item as either a concentrate or extract; (5) Date the concentrate or extract was made; (6) Net weight or volume in U.S. customary and metric units; (7) Serving size and number of servings per container; (8) Amount, in milligrams, of THC and CBD in each serving and in the container; (9) Activation time, expressed in words or through a pictogram; (10) Name of the lab that performed any test and any test analysis date; (11) Universal symbol; (12) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”; (13) For cannabinoid concentrates and extracts for sale to a consumer, warnings that state: (a) “For use only by adults 21 and older. Keep out of reach of children.” (b) “Do not drive a motor vehicle while under the influence of marijuana.” (c) “DO NOT EAT” in bold, capital letters. (14) For medical grade cannabinoid concentrates and extracts for use by a patient, the medical grade symbol and medical warnings that state: (a) “For use by OMMP patients only. Keep out of reach of children.” (b) “Do not drive a motor vehicle while under the influence of marijuana.” (c) “DO NOT EAT” in bold, capital letters.